Vigabatrin is an antiepileptic drug classified as an irreversible inhibitor of GABA transaminase, primarily indicated for the treatment of refractory epilepsy and infantile spasms. To support the rigorous… Read more










Vigabatrin is an antiepileptic drug classified as an irreversible inhibitor of GABA transaminase, primarily indicated for the treatment of refractory epilepsy and infantile spasms. To support the rigorous quality control and safety requirements of this medication, laboratories utilize a comprehensive range of related compounds. These include pharmacopeial and non-pharmacopeial impurities, degradation products, stereoisomers, and stable isotope labelled standards. These reference standards are essential tools for pharmaceutical laboratories performing impurity profiling, method validation, and long-term stability studies. Whether characterizing structurally related analogs, identifying degradation products resulting from hydrolytic or oxidative pathways, or quantifying specific nitroso derivatives, these materials enable high-precision analytical work. By utilizing these specialized analytical standards, researchers can ensure strict compliance with regulatory guidelines and maintain the analytical integrity of testing protocols throughout the drug’s lifecycle.